drugset / Trial / NCT01707667

Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity

NCT01707667

Phase 4 Completed 13 enrolled Shire
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the different effects of prucalopride and PEG 3350 + electrolytes on colon motor activity in subjects that are chronically constipated.

Timeline

Start
2013-02-27
Primary completion
2013-11-27
Completion
2013-11-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Prucalopride Small molecule 2 mg Oral
Comparator polyethylene glycol Other / unclassified 13.8 g Oral

Indications